Characteristics Associated with Acute-Phase Response following First Zoledronic Acid Infusion in Brazilian Population with Osteoporosis

We aimed to evaluate characteristics associated with acute-phase response (APR) following first zoledronic acid infusion in a Brazilian cohort. This retrospective cohort study enrolled all adults with osteoporosis who underwent a first zoledronic acid infusion at our centre between June 2015 and Jun...

Full description

Saved in:
Bibliographic Details
Main Authors: Bruno S. A. Ferreira, Bernardo M. da Cunha, Luciana P. Valadares, Larissa A. Moreira, Frederico G. A. Batista, Cristiane da F. Hottz, Marina M. P. Lins, Gabriel G. R. Magalhães, Luanna M. de Arruda, Sergio H. R. Ramalho
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Osteoporosis
Online Access:http://dx.doi.org/10.1155/2021/9492883
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552570880524288
author Bruno S. A. Ferreira
Bernardo M. da Cunha
Luciana P. Valadares
Larissa A. Moreira
Frederico G. A. Batista
Cristiane da F. Hottz
Marina M. P. Lins
Gabriel G. R. Magalhães
Luanna M. de Arruda
Sergio H. R. Ramalho
author_facet Bruno S. A. Ferreira
Bernardo M. da Cunha
Luciana P. Valadares
Larissa A. Moreira
Frederico G. A. Batista
Cristiane da F. Hottz
Marina M. P. Lins
Gabriel G. R. Magalhães
Luanna M. de Arruda
Sergio H. R. Ramalho
author_sort Bruno S. A. Ferreira
collection DOAJ
description We aimed to evaluate characteristics associated with acute-phase response (APR) following first zoledronic acid infusion in a Brazilian cohort. This retrospective cohort study enrolled all adults with osteoporosis who underwent a first zoledronic acid infusion at our centre between June 2015 and June 2019. Clinical demographics (age, sex, diabetes, smoking, body mass index, and previous oral bisphosphonate use) and laboratory data (calcium, parathyroid hormone, renal function, and serum 25-hydroxyvitamin D and carboxy-terminal crosslinked telopeptide of type 1 collagen [CTX], both before and after infusion) were compared between patients with and without APR. We evaluated association magnitude between the presence of APR and clinical variables through logistic regression. This study enrolled 400 patients (women, 80%). APR was observed in 24.5% (n = 98) of patients. The mean symptom duration in days was 3.5 ± 2.8. Patients with APR were younger (67 ± 12 vs. 71 ± 11 years; p=0.001), used oral bisphosphonates less frequently (34% × 50%; p=0.005), and had greater baseline CTX (0.535 ng/mL [0.375, 0.697] × 0.430 [0.249, 0.681]; p=0.03) and ΔCTX (−69 [−76; −50] × −54 [−72; −23]; p=0.002) than those without APR. The other variables were similar between the groups. Only ΔCTX was associated (OR, 0.62; 95% CI 0.41–0.98) with APR after accounting for age and bisphosphonate use. APR occurred in 24.5% of the cohort. Younger age and absence of prior oral bisphosphonate use were associated with APR following first zoledronic acid infusion. APR was associated with ΔCTX (but no other variables) after adjusting for these factors.
format Article
id doaj-art-688fd6d3379040648c0bfd99775f6aeb
institution Kabale University
issn 2042-0064
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Journal of Osteoporosis
spelling doaj-art-688fd6d3379040648c0bfd99775f6aeb2025-02-03T05:58:23ZengWileyJournal of Osteoporosis2042-00642021-01-01202110.1155/2021/9492883Characteristics Associated with Acute-Phase Response following First Zoledronic Acid Infusion in Brazilian Population with OsteoporosisBruno S. A. Ferreira0Bernardo M. da Cunha1Luciana P. Valadares2Larissa A. Moreira3Frederico G. A. Batista4Cristiane da F. Hottz5Marina M. P. Lins6Gabriel G. R. Magalhães7Luanna M. de Arruda8Sergio H. R. Ramalho9Rheumatology Private OfficeDepartment of Internal Medicine-RheumatologyDepartment of Internal Medicine-EndocrinologyDepartment of Internal Medicine-RheumatologyDepartment of Internal Medicine-NutrologyDepartment of Internal Medicine-GerontologyDepartment of Internal Medicine-GerontologyDepartment of Internal Medicine-GerontologyDepartment of Internal Medicine-Palliative CareDepartment of Clinical Research, CoordinatorWe aimed to evaluate characteristics associated with acute-phase response (APR) following first zoledronic acid infusion in a Brazilian cohort. This retrospective cohort study enrolled all adults with osteoporosis who underwent a first zoledronic acid infusion at our centre between June 2015 and June 2019. Clinical demographics (age, sex, diabetes, smoking, body mass index, and previous oral bisphosphonate use) and laboratory data (calcium, parathyroid hormone, renal function, and serum 25-hydroxyvitamin D and carboxy-terminal crosslinked telopeptide of type 1 collagen [CTX], both before and after infusion) were compared between patients with and without APR. We evaluated association magnitude between the presence of APR and clinical variables through logistic regression. This study enrolled 400 patients (women, 80%). APR was observed in 24.5% (n = 98) of patients. The mean symptom duration in days was 3.5 ± 2.8. Patients with APR were younger (67 ± 12 vs. 71 ± 11 years; p=0.001), used oral bisphosphonates less frequently (34% × 50%; p=0.005), and had greater baseline CTX (0.535 ng/mL [0.375, 0.697] × 0.430 [0.249, 0.681]; p=0.03) and ΔCTX (−69 [−76; −50] × −54 [−72; −23]; p=0.002) than those without APR. The other variables were similar between the groups. Only ΔCTX was associated (OR, 0.62; 95% CI 0.41–0.98) with APR after accounting for age and bisphosphonate use. APR occurred in 24.5% of the cohort. Younger age and absence of prior oral bisphosphonate use were associated with APR following first zoledronic acid infusion. APR was associated with ΔCTX (but no other variables) after adjusting for these factors.http://dx.doi.org/10.1155/2021/9492883
spellingShingle Bruno S. A. Ferreira
Bernardo M. da Cunha
Luciana P. Valadares
Larissa A. Moreira
Frederico G. A. Batista
Cristiane da F. Hottz
Marina M. P. Lins
Gabriel G. R. Magalhães
Luanna M. de Arruda
Sergio H. R. Ramalho
Characteristics Associated with Acute-Phase Response following First Zoledronic Acid Infusion in Brazilian Population with Osteoporosis
Journal of Osteoporosis
title Characteristics Associated with Acute-Phase Response following First Zoledronic Acid Infusion in Brazilian Population with Osteoporosis
title_full Characteristics Associated with Acute-Phase Response following First Zoledronic Acid Infusion in Brazilian Population with Osteoporosis
title_fullStr Characteristics Associated with Acute-Phase Response following First Zoledronic Acid Infusion in Brazilian Population with Osteoporosis
title_full_unstemmed Characteristics Associated with Acute-Phase Response following First Zoledronic Acid Infusion in Brazilian Population with Osteoporosis
title_short Characteristics Associated with Acute-Phase Response following First Zoledronic Acid Infusion in Brazilian Population with Osteoporosis
title_sort characteristics associated with acute phase response following first zoledronic acid infusion in brazilian population with osteoporosis
url http://dx.doi.org/10.1155/2021/9492883
work_keys_str_mv AT brunosaferreira characteristicsassociatedwithacutephaseresponsefollowingfirstzoledronicacidinfusioninbrazilianpopulationwithosteoporosis
AT bernardomdacunha characteristicsassociatedwithacutephaseresponsefollowingfirstzoledronicacidinfusioninbrazilianpopulationwithosteoporosis
AT lucianapvaladares characteristicsassociatedwithacutephaseresponsefollowingfirstzoledronicacidinfusioninbrazilianpopulationwithosteoporosis
AT larissaamoreira characteristicsassociatedwithacutephaseresponsefollowingfirstzoledronicacidinfusioninbrazilianpopulationwithosteoporosis
AT fredericogabatista characteristicsassociatedwithacutephaseresponsefollowingfirstzoledronicacidinfusioninbrazilianpopulationwithosteoporosis
AT cristianedafhottz characteristicsassociatedwithacutephaseresponsefollowingfirstzoledronicacidinfusioninbrazilianpopulationwithosteoporosis
AT marinamplins characteristicsassociatedwithacutephaseresponsefollowingfirstzoledronicacidinfusioninbrazilianpopulationwithosteoporosis
AT gabrielgrmagalhaes characteristicsassociatedwithacutephaseresponsefollowingfirstzoledronicacidinfusioninbrazilianpopulationwithosteoporosis
AT luannamdearruda characteristicsassociatedwithacutephaseresponsefollowingfirstzoledronicacidinfusioninbrazilianpopulationwithosteoporosis
AT sergiohrramalho characteristicsassociatedwithacutephaseresponsefollowingfirstzoledronicacidinfusioninbrazilianpopulationwithosteoporosis